Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PegIntron in Chronic Hepatitis B and D Co-infection
NCT00686790Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Dec 2005
- Primary completion
- May 2009
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
01
Overview
A Phase 3 trial of peginterferon alfa-2b in chronic hepatitis D, Chronic Hepatitis B (CHB), sponsored by Merck & Co.. Started Dec 2005; status: completed.
02
Drugs
peginterferon alfa-2b
03
Conditions
chronic hepatitis DChronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00686790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00686790.